% Options for packages loaded elsewhere
\PassOptionsToPackage{unicode}{hyperref}
\PassOptionsToPackage{hyphens}{url}
%
\documentclass[
  12pt,
]{article}
\usepackage{amsmath,amssymb}
\usepackage{iftex}
\ifPDFTeX
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provide euro and other symbols
\else % if luatex or xetex
  \usepackage{unicode-math} % this also loads fontspec
  \defaultfontfeatures{Scale=MatchLowercase}
  \defaultfontfeatures[\rmfamily]{Ligatures=TeX,Scale=1}
\fi
\usepackage{lmodern}
\ifPDFTeX\else
  % xetex/luatex font selection
\fi
% Use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
\IfFileExists{microtype.sty}{% use microtype if available
  \usepackage[]{microtype}
  \UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\makeatletter
\@ifundefined{KOMAClassName}{% if non-KOMA class
  \IfFileExists{parskip.sty}{%
    \usepackage{parskip}
  }{% else
    \setlength{\parindent}{0pt}
    \setlength{\parskip}{6pt plus 2pt minus 1pt}}
}{% if KOMA class
  \KOMAoptions{parskip=half}}
\makeatother
\usepackage{xcolor}
\usepackage[margin=1in]{geometry}
\usepackage{longtable,booktabs,array}
\usepackage{calc} % for calculating minipage widths
% Correct order of tables after \paragraph or \subparagraph
\usepackage{etoolbox}
\makeatletter
\patchcmd\longtable{\par}{\if@noskipsec\mbox{}\fi\par}{}{}
\makeatother
% Allow footnotes in longtable head/foot
\IfFileExists{footnotehyper.sty}{\usepackage{footnotehyper}}{\usepackage{footnote}}
\makesavenoteenv{longtable}
\usepackage{graphicx}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
% Set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother
\setlength{\emergencystretch}{3em} % prevent overfull lines
\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}
\setcounter{secnumdepth}{-\maxdimen} % remove section numbering
\usepackage{graphicx}
\usepackage{booktabs}
\usepackage{float}
\usepackage{amsmath}
\usepackage{fancyhdr}
\usepackage{lastpage}
\usepackage{hyperref}
\newpage
\hypersetup{colorlinks=true, linkcolor=blue, filecolor=magenta, urlcolor=cyan}
\urlstyle{same}
\pagestyle{fancy}
\fancyhead[L]{ISO 10993-5 Cytotoxicity Test Report}
\fancyhead[R]{ACME Labs Inc.}
\fancyfoot[C]{Page \thepage\ of \pageref{LastPage}}
\ifLuaTeX
  \usepackage{selnolig}  % disable illegal ligatures
\fi
\usepackage{bookmark}
\IfFileExists{xurl.sty}{\usepackage{xurl}}{} % add URL line breaks if available
\urlstyle{same}
\hypersetup{
  pdftitle={ISO 10993-5 MEM Elution Test Report},
  hidelinks,
  pdfcreator={LaTeX via pandoc}}

\title{ISO 10993-5 MEM Elution Test Report}
\usepackage{etoolbox}
\makeatletter
\providecommand{\subtitle}[1]{% add subtitle to \maketitle
  \apptocmd{\@title}{\par {\large #1 \par}}{}{}
}
\makeatother
\subtitle{Assessment of Dehydrated Boulders}
\author{\vspace{20pt}

Wile E. Coyote\\
ACME Corporation\\
123 Research Ave\\
Burbank, CA, 91501\\
USA Prepared by:\\
Test Facility:\\}
\date{September 22, 2024}

\begin{document}
\maketitle
\begin{abstract}
This report summarizes the results of the MEM Elution assay for the
cytotoxicity testing of Dehydrated Boulders. The purpose of this test is
to assess the cytotoxic potential of the test article to determine if
the material exhibits any toxic effects on mammalian cells.
\end{abstract}

{
\setcounter{tocdepth}{2}
\tableofcontents
}
\newpage

\subsection{Quality Assurance
Statement}\label{quality-assurance-statement}

The Quality Assurance Unit inspected/audited this study in compliance
with the following regulations:

\textbf{Good Laboratory Practice for Nonclinical Laboratory Studies,
Title 21 of the Code of Federal Regulations, Part 58 (21 CFR Part 58)}

\subsection{Inspections Overview}\label{inspections-overview}

The Quality Assurance Unit conducted inspections on the following dates.
The findings were reported to the Study Director. The final report was
reviewed by the Quality Assurance Unit. The final report accurately
describes the test methods in accordance with standard operating
procedures, and the results are consistent with raw data from
non-clinical studies conducted according to the study protocol.

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2466}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2466}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2466}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2603}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
Inspection
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Date of Inspection
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Performed by
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Date Reported to Study Director
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Study Protocol & 2024-09-07 & Mr.~Bugs Bunny & 2024-09-07 \\
Study Procedure & 2024-09-11 & Mr.~Bugs Bunny & 2024-09-07 \\
Raw Data & 2024-09-14 & Mr.~Bugs Bunny & 2024-09-14 \\
Final Report & 2024-09-15 & Mr.~Bugs Bunny & 2024-09-15 \\
\end{longtable}

\begin{tabular}{p{6cm} p{6cm}}
  \\[10mm]
  \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ & \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ \\
   Mr. Bugs Bunny  & Date \\
  Quality Manager &  \\[10mm]
  \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ & \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ \\
   Wile E. Coyote  & Date \\
  Study Director &  \\
  \end{tabular}

\newpage

\subsection{GLP Compliance Statement}\label{glp-compliance-statement}

This study was fully in accordance with the technical requirements of
the study protocol.

This study was conducted in compliance with Good Laboratory Practice
(GLP) Regulation 21 CFR Part 58, U.S. Food and Drug Administration
(FDA).

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.4225}}
  >{\raggedleft\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.5775}}@{}}
\toprule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Test Article Receipt & 2024-09-01 \\
Protocol Effective Date & 2024-09-07 \\
Technical Initiation Date & 2024-09-08 \\
Technical Completion Date & 2024-09-13 \\
Final Report Completion Date & 2024-09-15 \\
\end{longtable}

\begin{tabular}{p{6cm} p{6cm}}
  \\[10mm]
  \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ & \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ \\
   Mr. Bugs Bunny  & Date \\
  Quality Manager &  \\[10mm] % Adds 10mm vertical space before the signature
  % Adding a second signature line for Study Director
  \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ & \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ \\
   Wile E. Coyote  & Date \\
  Study Director &  \\
  \end{tabular}

\newpage

\subsection{Summary}\label{summary}

\subsubsection{Test and Control
Articles}\label{test-and-control-articles}

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
\textbf{Article Type}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Name}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Lot Number}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Expiration}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Storage}
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Test Article & Dehydrated Boulders & BB1940WSC & 2025-12-31 & Room
temperature \\
Negative Control & Polyethylene Pellets & POLY-LOT-5678 & 2025-03-15 &
Room temperature \\
Positive Control & Latex & LATEX-LOT-1234 & 2025-06-30 & Room
temperature \\
Blank Control & N/A & --- & N/A & Room temperature \\
\end{longtable}

\subsubsection{Test Method}\label{test-method}

Potential toxicity of test article was evaluated using the MEM Elution
method in accordance with ISO 10993-5: 2009 Biological evaluation of
Medical Devices---Part 5: Tests for in vitro Cytotoxicity. Study
protocol number: ACME-CYTO

\subsubsection{Conclusion}\label{conclusion}

Under the conditions of this study, the test article extract did not
show cytotoxic potential when testing on L929 cells.

\newpage

\subsection{Purpose}\label{purpose}

The purpose of this test was to determine the biological reactivity of
mouse fibroblast L929 cells in response to the test article---Dehydrated
Boulders. This study evaluated whether the test article exhibited any
toxic effects on mammalian cells under in vitro conditions.
Specifically, the test assessed the cytotoxic potential to determine the
safety and biocompatibility of the material when used according to its
intended purpose.

\subsection{Regulatory Standards}\label{regulatory-standards}

This study was conducted in accordance with the following regulatory
standards:

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  \textbf{ISO 10993-1}: \emph{Evaluation and Testing within a Risk
  Management Process}---General requirements for evaluating the
  biological impact of medical devices.\\
\item
  \textbf{ISO 10993-5:2009}: \emph{Biological Evaluation of Medical
  Devices---Part 5: Tests for in vitro Cytotoxicity}---Provides
  guidelines for evaluating the potential cytotoxic effects of a medical
  device material on cells.\\
\item
  \textbf{ISO 10993-12}: \emph{Sample Preparation and Reference
  Materials}---Guidelines for preparing samples and reference materials
  for testing to ensure consistent and reliable results.
\end{enumerate}

These standards ensure that the study was conducted with the highest
level of scientific rigor and consistency, providing a reliable
assessment of the biological impact of the test article.

\subsection{Compliance}\label{compliance}

This study complies with the following regulations:

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\item
  \textbf{Good Laboratory Practice (GLP) Regulations (21 CFR Part 58)}:
  GLP standards ensure that the study is conducted with transparency,
  accountability, and rigorous scientific practices, guaranteeing the
  integrity of the study data.
\item
  \textbf{ISO/IEC 17025:2017}: \emph{General Requirements for the
  Competence of Testing and Calibration Laboratories}---ISO 17025
  accreditation ensures that the testing facility is competent to
  perform laboratory testing with a high degree of accuracy and
  reliability.
\end{enumerate}

Compliance with these regulations guarantees that the study data meets
both legal and quality assurance requirements, ensuring the validity and
credibility of the test results.

\newpage

\subsection{Test and Control
Articles}\label{test-and-control-articles-1}

\subsubsection{Test Article}\label{test-article}

\begin{longtable}[]{@{}ll@{}}
\toprule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
\textbf{Name} & Dehydrated Boulders \\
\textbf{Manufacturer} & ACME Corporation \\
\textbf{Batch/Lot Number} & BB1940WSC \\
\textbf{Expiration Date} & 2025-12-31 \\
\textbf{Storage Conditions} & Room temperature \\
\end{longtable}

*Note** The information about the test article was supplied by the
sponsor wherever applicable. The Sponsor is responsible for all test
article characterization data as specified in the GLP.

\subsubsection{Negative Control Article}\label{negative-control-article}

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.3429}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.6571}}@{}}
\toprule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
\textbf{Name} & High-density Polyethylene (HDPE) \\
\textbf{Extraction Ratio} & 3 cm²/1 mL \\
\textbf{Physical State} & Solid \\
\textbf{Color} & White \\
\textbf{Storage Conditions} & Room temperature \\
\textbf{Extraction Solvent} & MEM medium with 10\% fetal bovine serum
(FBS) \\
\end{longtable}

\subsubsection{Positive Control Article}\label{positive-control-article}

\begin{longtable}[]{@{}ll@{}}
\toprule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
\textbf{Name} & Latex \\
\textbf{Extraction Ratio} & 3 cm²/1 mL \\
\textbf{Physical State} & Solid \\
\textbf{Color} & Tan \\
\textbf{Storage Conditions} & Room temperature \\
\textbf{Extraction Solvent} & MEM medium with 10\% FBS \\
\end{longtable}

\subsubsection{Media Control}\label{media-control}

MEM medium with 10\% fetal bovine serum (FBS)

\newpage

\subsection{Equipment and Reagents}\label{equipment-and-reagents}

\subsubsection{Equipment}\label{equipment}

\begin{longtable}[]{@{}lll@{}}
\toprule\noalign{}
\textbf{Equipment Name} & \textbf{Equipment Number} &
\textbf{Calibration Expire} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Autoclave & ACME-001 & 2025-03-09 \\
CO2 Incubator & BUGS-006 & 2025-03-09 \\
Inverted microscope & DAFFY-007 & 2025-06-15 \\
\end{longtable}

\subsubsection{Reagents}\label{reagents}

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2533}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.1867}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.1867}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.1867}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.1867}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
\textbf{Reagent Name}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Manufacturer}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Part Number}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Lot Number}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Expiration Date}
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Fetal Bovine Serum (FBS) & Wile E. Biotech Industries & FBS-002 &
FBS-LOT-2024 & 2025-01-31 \\
MEM Medium & Road Runner Labs & MEM-003 & MEM-LOT-5678 & 2025-06-30 \\
Trypsin & Bugs Bunny Pharmaceuticals & TRYPSIN-004 & TRYPSIN-LOT-9012 &
2025-08-15 \\
Penicillin/Streptomycin & Daffy Duck Labs & PENSTREP-005 &
PENSTREP-LOT-3456 & 2025-11-01 \\
PBS (Phosphate-buffered saline) & Tweety Solutions & PBS-006 &
PBS-LOT-7890 & 2026-01-20 \\
Isopropanol (99.9\%) & ACME Industrial Reagents & ISO-007 & ISO-LOT-1122
& 2026-03-15 \\
\end{longtable}

\subsection{Identification of Test
System}\label{identification-of-test-system}

L929 mouse fibroblast cells obtained from ATCC (American Type Culture
Collection), USA.

\subsection{Justification of Test System and Route of
Administration}\label{justification-of-test-system-and-route-of-administration}

Historically, mouse fibroblast L929 cells have been used for
cytotoxicity studies because they demonstrate sensitivity to extractable
cytotoxic articles. The test article was extracted and administered in
vitro to mouse fibroblast L929 cells through a solvent compatible with
the test system. This was the optimal route of administration available
in this test system as recommended in the guidelines.

\newpage

\subsection{Experimental Design}\label{experimental-design}

\subsubsection{Extraction Process}\label{extraction-process}

The extraction process was carried out at an extraction ratio of
\textbf{3 cm³:1 mL} for all samples. Under aseptic conditions, samples
were extracted with continuous agitation in closed, inert containers,
using \textbf{DMEM medium with 10\% fetal bovine serum (FBS)} as the
extraction solvent.

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 4\tabcolsep) * \real{0.2778}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 4\tabcolsep) * \real{0.3472}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 4\tabcolsep) * \real{0.3750}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
\textbf{Sample}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Extract Volume (mL)}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Appearance of Extract}
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Test Article & 64.9 mL & Clear \\
Negative Control & 64.9 mL & Clear \\
Positive Control & 64.9 mL & Cloudy \\
Blank Control & 64.9 mL & Clear \\
\end{longtable}

\subsection{Experimental Procedure}\label{experimental-procedure}

Once the extracts were prepared, they were tested on \textbf{L929 mouse
fibroblast cells} using a standard cytotoxicity assay. The cells were
cultured in a 96-well plate and exposed to the test article extract and
controls for approximately 48 hours.

\subsubsection{Evaluation Criteria}\label{evaluation-criteria}

Morphological assessment of cytotoxicity was based on the following
grading system:

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.2917}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.7083}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
\textbf{Grade}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Criteria}
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
\textbf{0 - None} & No cell lysis observed; cells remained attached,
with intracytoplasmic granules. \\
\textbf{1 - Slight} & ≤ 20\% rounding of cells, with occasional lysed
cells observed. \\
\textbf{2 - Mild} & \textgreater{} 20\% to ≤ 50\% rounding, with no
extensive cell lysis. \\
\textbf{3 - Moderate} & \textgreater{} 50\% rounding, with lysed cells
present. \\
\textbf{4 - Severe} & Nearly complete destruction of the cell layer,
with extensive lysis. \\
\end{longtable}

\subsubsection{Statistical Method}\label{statistical-method}

The mode of three replicates will be calculated to evaluate cytotoxic
potential.

\newpage

\subsection{Results}\label{results}

\subsubsection{Pre-Extraction
Observations}\label{pre-extraction-observations}

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.2982}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.7018}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
\textbf{Observation}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Details}
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Pre-Extraction & All extracts were clear and free of particulates prior
to the extraction process. \\
\end{longtable}

\subsubsection{Post-Extraction
Observations}\label{post-extraction-observations}

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.3462}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 2\tabcolsep) * \real{0.6538}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
\textbf{Sample}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Post-Extraction Observation}
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Test Article & No significant color changes were observed, and the
extract remained clear. \\
Negative Control & No significant color changes were observed, and the
extract remained clear. \\
Positive Control & The extract became cloudy, and filtration was
required before use. \\
\end{longtable}

\textbf{General Observations}

No pH adjustments, centrifugation, or dilution processes were performed
on the test and control samples.

\textbf{Post-Extraction Observation}

\begin{itemize}
\tightlist
\item
  \textbf{Test Article}: No significant color changes were observed, and
  the extract remained clear.
\item
  \textbf{Negative Control}: No significant color changes were observed,
  and the extract remained clear.
\item
  \textbf{Positive Control}: The extract became cloudy, and filtration
  was required before use.
\end{itemize}

No pH adjustments, centrifugation, or dilution processes were performed
on the test and control samples.

\subsubsection{Morphological Scoring}\label{morphological-scoring}

Each sample was tested in triplicate. The table below shows the results
of the qualitative assessment of cytotoxicity:

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2000}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
\textbf{Sample}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Replicate 1}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Replicate 2}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Replicate 3}
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
\textbf{Modal Score}
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Test Article & 0 (None) & 0 (None) & 0 (None) & 0 (None) \\
Positive Control & 4 (Severe) & 4 (Severe) & 4 (Severe) & 4 (Severe) \\
Negative Control & 0 (None) & 0 (None) & 0 (None) & 0 (None) \\
Blank Control & 0 (None) & 0 (None) & 0 (None) & 0 (None) \\
\end{longtable}

\subsection{Conclusion}\label{conclusion-1}

The \textbf{test article extract}, when tested in triplicate, did not
exhibit any cytotoxic effects at the tested concentration, as indicated
by the \textbf{modal reactivity score} of \textbf{0 (None)}. The
positive control demonstrated expected \textbf{severe cytotoxicity},
while the negative and blank controls showed \textbf{no cytotoxicity}.

\subsection{Record Storage}\label{record-storage}

All raw data generated during this study, along with a copy of the final
report, have been securely archived at \textbf{ACME Labs}' designated
storage facility in accordance with internal protocols and regulatory
requirements.

\subsection{Confidentiality Agreement}\label{confidentiality-agreement}

The confidentiality of all data and study-related materials has been
maintained as per the confidentiality agreement established prior to the
initiation of the study.

\subsection{Deviation Statement}\label{deviation-statement}

There were no deviations from the approved study protocol that would
impact the validity or integrity of the data.

\end{document}
